<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Juarez Lund | Activity</title>
	<link>https://recash.wpsoul.net/members/bankerstock19/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/bankerstock19/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Juarez Lund.</description>
	<lastBuildDate>Sun, 26 Jul 2026 08:21:20 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">1a33a5a48cc92f271a99da21c6d1898c</guid>
				<title>Juarez Lund posted an update: We used C-G evaporation model to estimate evaporation ratio [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/134098/</link>
				<pubDate>Wed, 01 Jan 2025 11:01:00 +0000</pubDate>

									<content:encoded><![CDATA[<p>We used C-G evaporation model to estimate evaporation ratio E/V of canal water, and results show a ratio of evaporation loss of 2.54% ~ 3.73% in July 2018 and 1.66% ~ 2.39% in April 2019. We also found obvious seasonal differences existed in canal water isotopes, evaporation enrichment and the CWEL (canal water evaporation line), in association&hellip;<span class="activity-read-more" id="activity-read-more-134098"><a href="https://recash.wpsoul.net/activity/p/134098/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">898cd3ec7ec374fd47297904cfc0cb89</guid>
				<title>Juarez Lund posted an update: Current type 2 diabetes (T2D) management contraindicates [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/116443/</link>
				<pubDate>Thu, 26 Dec 2024 11:26:19 +0000</pubDate>

									<content:encoded><![CDATA[<p>Current type 2 diabetes (T2D) management contraindicates intensive glycemia treatment in patients with high cardiovascular disease (CVD) risk and is partially motivated by evidence of harms in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Heterogeneity in response to intensive glycemia treatment has been observed,&hellip;<span class="activity-read-more" id="activity-read-more-116443"><a href="https://recash.wpsoul.net/activity/p/116443/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f960f6f1469d4cfcd0f6e5714745103d</guid>
				<title>Juarez Lund became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/92430/</link>
				<pubDate>Fri, 20 Dec 2024 11:54:54 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>